These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38018236)

  • 21. Pediatric hidradenitis suppurativa publication trends: 2012 to 2022.
    Park SE; Shih T; Dagenet C; Hogeling M; Hughes M; Gillenwater J; Shi VY; Hsiao JL
    Pediatr Dermatol; 2024; 41(3):472-475. PubMed ID: 38409741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shorter time to initiation of biologic therapy in the setting of a hidradenitis suppurativa specialty clinic.
    Kearney N; O'Donohoe S; Hughes R; Kirby B
    Clin Exp Dermatol; 2023 Sep; 48(10):1149-1151. PubMed ID: 37256275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practical Guidelines for Managing Patients With Hidradenitis Suppurativa: An Update.
    Johnston LA; Alhusayen R; Bourcier M; Delorme I; George R; O'Brien E; Wong SM; Poelman SM
    J Cutan Med Surg; 2022; 26(2_suppl):2S-24S. PubMed ID: 36000460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018.
    Posso-De Los Rios CJ; Sarfo A; Ghias M; Alhusayen R; Hamzavi I; Lowes MA; Alavi A
    Exp Dermatol; 2019 Jul; 28(7):769-775. PubMed ID: 30924968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.
    Thorlacius L; Garg A; Riis PT; Nielsen SM; Bettoli V; Ingram JR; Del Marmol V; Matusiak L; Pascual JC; Revuz J; Sartorius K; Tzellos T; van der Zee HH; Zouboulis CC; Saunte DM; Gottlieb AB; Christensen R; Jemec GBE
    Br J Dermatol; 2019 Sep; 181(3):483-491. PubMed ID: 30724351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hidradenitis suppurativa in the pediatric population.
    Liy-Wong C; Pope E; Lara-Corrales I
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventions for hidradenitis suppurativa.
    Ingram JR; Woo PN; Chua SL; Ormerod AD; Desai N; Kai AC; Hood K; Burton T; Kerdel F; Garner SE; Piguet V
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010081. PubMed ID: 26443004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing antibiotic prescribing patterns for hidradenitis suppurativa between dermatology and non-dermatology ambulatory providers.
    Tolson H; Kikuchi R; Yamamoto RK; Sadrolashrafi K; Guo L; Hao A; Bilimoria S; Yee D; Armstrong AW
    Skin Health Dis; 2024 Oct; 4(5):e451. PubMed ID: 39355735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective review of light- and laser-based management of hidradenitis suppurativa.
    Levoska MA; Nicholson CL; Hamzavi IH
    Semin Cutan Med Surg; 2017 Jun; 36(2):67-74. PubMed ID: 28538747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice.
    Orenstein LAV; Nguyen TV; Damiani G; Sayed C; Jemec GBE; Hamzavi I
    Dermatology; 2020; 236(5):393-412. PubMed ID: 32408306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [CME Dermatology 23/Answers: Hidradenitis suppurativa].
    Dahmen RA; Lautenschlager S
    Praxis (Bern 1994); 2021 Jun; 110(8):471-472. PubMed ID: 34107755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
    Chernyshov PV; Zouboulis CC; Tomas-Aragones L; Jemec GB; Svensson A; Manolache L; Tzellos T; Sampogna F; Pustisek N; van der Zee HH; Marron SE; Spillekom-van Koulil S; Bewley A; Linder D; Abeni D; Szepietowski JC; Augustin M; Finlay AY
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1633-1643. PubMed ID: 31037773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical and psychosocial comorbidities of pediatric hidradenitis suppurativa: A retrospective analysis.
    Seivright JR; Collier E; Grogan T; Hogeling M; Shi VY; Hsiao JL
    Pediatr Dermatol; 2021 Sep; 38(5):1132-1136. PubMed ID: 34463372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of medical treatments for pediatric hidradenitis suppurativa: A systematic review.
    Masson R; Ma E; Parvathala N; Shih T; Atluri S; Hogeling M; Hughes M; Sayed CJ; Shi VY; Hsiao JL
    Pediatr Dermatol; 2023; 40(5):775-788. PubMed ID: 37525978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ustekinumab with Intravenous Infusion: Results in Hidradenitis Suppurativa.
    Romaní J; Vilarrasa E; Martorell A; Fuertes I; Ciudad C; Molina-Leyva A
    Dermatology; 2020; 236(1):21-24. PubMed ID: 31288233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document.
    Alavi A; Lynde C; Alhusayen R; Bourcier M; Delorme I; George R; Gooderham M; Gulliver W; Kalia S; Marcoux D; Poulin Y
    J Cutan Med Surg; 2017; 21(6):513-524. PubMed ID: 28639459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hidradenitis Suppurativa Associated with Down Syndrome Is Characterized by Early Age at Diagnosis.
    Giovanardi G; Chiricozzi A; Bianchi L; De Simone C; Dini V; Franceschini C; Garcovich S; Oranges T; Di Raimondo C; Caposiena Caro DR; Romanelli M; Peris K
    Dermatology; 2018; 234(1-2):66-70. PubMed ID: 29689550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [S1 guideline for the treatment of hidradenitis suppurativa / acne inversa * (number ICD-10 L73.2)].
    Zouboulis CC; Bechara FG; Fritz K; Kurzen H; Liakou AI; Marsch WC; Milling A; Nast A; Podda M; Taube KM; Wienert V; Winkler T; ; ; ; ; ; ; ; ;
    J Dtsch Dermatol Ges; 2012 Oct; 10 Suppl 5():S1-31. PubMed ID: 22925400
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessing unmet needs in patients with hidradenitis suppurativa.
    Chadha SA; Stout MA; Goyal PK; Nguyen CV; Lu KQ
    Arch Dermatol Res; 2023 Nov; 315(9):2555-2560. PubMed ID: 37264285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.